1. Home
  2. CTRI vs IMNM Comparison

CTRI vs IMNM Comparison

Compare CTRI & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

HOLD

Current Price

$30.60

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$20.58

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRI
IMNM
Founded
1909
2006
Country
United States
United States
Employees
9687
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
CTRI
IMNM
Price
$30.60
$20.58
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$29.85
$32.80
AVG Volume (30 Days)
1.5M
906.1K
Earning Date
02-25-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
412.50
51.40
EPS
0.25
N/A
Revenue
$2,982,781,000.00
$6,941,000.00
Revenue This Year
$13.82
$18.41
Revenue Next Year
$8.39
$863.23
P/E Ratio
$122.40
N/A
Revenue Growth
13.10
N/A
52 Week Low
$14.46
$5.15
52 Week High
$32.38
$27.65

Technical Indicators

Market Signals
Indicator
CTRI
IMNM
Relative Strength Index (RSI) 55.87 41.75
Support Level $19.76 $18.98
Resistance Level $32.38 $22.57
Average True Range (ATR) 1.11 1.10
MACD -0.11 -0.07
Stochastic Oscillator 77.33 25.75

Price Performance

Historical Comparison
CTRI
IMNM

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: